{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:35Z","timestamp":1786119695141,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1097\/01.inf.0000055095.84136.a2","type":"journal-article","created":{"date-parts":[[2011,4,11]],"date-time":"2011-04-11T04:00:53Z","timestamp":1302494453000},"page":"268-272","source":"Crossref","is-referenced-by-count":36,"title":["One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial"],"prefix":"10.1097","volume":"22","author":[{"given":"PRATIBHA","family":"SINGHI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DEVI","family":"DAYAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"KHANDELWAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210201","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/clinids\/24.2.101","article-title":"Neurocysticercosis: a major cause of neurological disease worldwide","volume":"24","author":"White","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R2-13-20210201","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJM198412063112307","article-title":"Recent advances in the diagnosis and treatment of cerebral cysticercosis","volume":"311","author":"Nash","year":"1984","journal-title":"N Engl J Med"},{"key":"R3-13-20210201","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archinte.1987.00370040120021","article-title":"Albendazole therapy for cysticercosis","volume":"147","author":"Escobedo","year":"1987","journal-title":"Arch Intern Med"},{"key":"R4-13-20210201","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archneur.1988.00520290064015","article-title":"Albendazoleversuspraziquantel for therapy for neurocysticercosis: a controlled trial","volume":"45","author":"Sotelo","year":"1988","journal-title":"Arch Neurol"},{"key":"R5-13-20210201","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/archneur.1988.00520340084017","article-title":"Short course of albendazole therapy for neurocysticercosis","volume":"45","author":"Sotelo","year":"1988","journal-title":"Arch Neurol"},{"key":"R6-13-20210201","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archneur.1992.00530270106026","article-title":"Therapy for neurocysticercosis. Comparison between albendazole and praziquantel","volume":"49","author":"Takayanagui","year":"1992","journal-title":"Arch Neurol"},{"key":"R7-13-20210201","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0035-9203(91)90041-V","article-title":"albendazolevs.praziquantel in the treatment of cerebral cysticercosis: clinical evaluation","volume":"85","author":"Cruz","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R8-13-20210201","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/0035-9203(93)90095-8","article-title":"Short course albendazole treatment for neurocysticercosis in Colombia","volume":"87","author":"Botero","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"R9-13-20210201","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00314663","article-title":"Comparison of therapeutic regimens of anticysticercal drugs for parenchymal brain cysticercosis","volume":"237","author":"Sotelo","year":"1990","journal-title":"J Neurol"},{"key":"R10-13-20210201","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00006454-199808000-00007","article-title":"Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial","volume":"17","author":"Baranwal","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"R11-13-20210201","first-page":"76","article-title":"Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment","volume":"82","author":"Mitchell","year":"1988","journal-title":"Pediatrics"},{"key":"R12-13-20210201","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1148\/radiology.171.2.2704811","article-title":"Cerebral cysticercosis: documentation of natural history with CT","volume":"171","author":"Kramer","year":"1989","journal-title":"Radiology"},{"key":"R13-13-20210201","first-page":"255","article-title":"Albendazole in neurocysticercosis","volume":"8","author":"Padma","year":"1995","journal-title":"Natl Med J India"},{"key":"R14-13-20210201","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-3156.1999.00477.x","article-title":"Treating neurocysticercosis medically: a systematic review of randomized, controlled trials","volume":"4","author":"Salinas","year":"1999","journal-title":"Trop Med Int Health"},{"key":"R15-13-20210201","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/archneur.1989.00520470099034","article-title":"Neurocysticercosis: short course of treatment with albendazole","volume":"46","author":"Alarcon","year":"1989","journal-title":"Arch Neurol"},{"key":"R16-13-20210201","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0022-510X(95)00181-Z","article-title":"Neurocysticercosis: optimal dose treatment with albendazole","volume":"133","author":"Cruz","year":"1995","journal-title":"J Neurol Sci"},{"key":"R17-13-20210201","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1212\/WNL.48.5.1421","article-title":"Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7versus14 days of treatment","volume":"48","author":"Garcia","year":"1997","journal-title":"Neurology"},{"key":"R18-13-20210201","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/111.3.597","article-title":"Disseminated cysticercosis: new observations including CT scan findings and experience with treatment by praziquantel","volume":"111","author":"Wadia","year":"1998","journal-title":"Brain"},{"key":"R19-13-20210201","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/infdis\/175.2.486","article-title":"Serologic evolution of neurocysticercosis patients after antiparasitic therapy: Cysticercosis Working Group in Peru","volume":"175","author":"Garcia","year":"1997","journal-title":"J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.inf.0000055095.84136.a2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:11:20Z","timestamp":1786043480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200303000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.1097\/01.inf.0000055095.84136.a2","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}